CARDIOPULMONARY BYPASS EQUIPMENT MARKET ANALYSIS

Market Size and Trends

Global cardiopulmonary bypass equipment market is estimated to be valued at US$ 205.1 Mn in 2024 and is expected to reach USD 246.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 2.6 % from 2024 to 2031.

To learn more about this report, request a free sample copy

Global cardiopulmonary bypass equipment market is expected to witness a steady growth over the forecast period due to increasing prevalence of cardiovascular diseases and growing demand for minimally invasive surgeries.  Moreover, advancement in clinical research for improving bypass equipment and rising healthcare expenditure can also drive the market growth during this period. However, high costs associated with cardiopulmonary bypass surgeries and lack of awareness in developing regions are expected to hinder the market growth.

Rising Burden of Cardiovascular Diseases

Rising prevalence of cardiovascular diseases across the world can boost demand for cardiopulmonary bypass equipment. Cardiovascular diseases are the leading causes of mortality worldwide. According to the data published by the World Health Organization, cardiovascular diseases accounted for over 17 million deaths in 2015, which is estimated to grow to over 23 million by 2030. Growing geriatric population base can increase the risk of various heart conditions. Moreover, changing lifestyles and increasing consumption of unhealthy diets have also contributed to rising incidence of diseases like coronary artery disease and heart failure. This has significantly boosted the number of open-heart surgeries and other cardiac procedures performed annually. Cardiopulmonary bypass is essential for most of these surgical interventions.  For Instance, according to the World Heart Federation in 2024, global deaths from cardiovascular disease (CVD) had increased from 12.1 million in 1990 to 20.5 million in 2021, making CVD the leading cause of death worldwide in 2021, with the majority occurring in low- and middle-income countries (LMICs). The World Heart Report, released at the 2023 World Heart Summit, offers the first comprehensive analysis of CVD risk and mortality data globally, thus, highlighting significant regional disparities. Despite an overall increase in CVD deaths over the past three decades, the global CVD death rate had decreased from 354.5 to 239.9 deaths per 100,000 people between 1990 and 2019, with high-income countries experiencing the most rapid decline.

Market Concentration and Competitive Landscape

To learn more about this report, request a free sample copy

Technological Advancements

Constant technological advancements can boost demand for cardiopulmonary bypass equipment. Vendors are continually focusing on developing novel product ranges with added features to improve therapeutic outcomes. For instance, new cardiopulmonary bypass machines feature miniaturized components for minimal invasiveness. Advanced bubble oxygenators enables homogeneous gas transfer without affecting blood flow regulation. Next-generation heart-lung machines are outfitted with enhanced safety alarms and automated regulatory mechanisms. Such innovations allows for more efficient and controlled CBP procedures. The introduction of affordable equipment variants increases access in price-sensitive low and middle-income markets. The integration of virtual technologies like artificial intelligence and machine learning improves intra-operative decision making and reduce manual errors. Rising investments by players towards R&D of more innovative solutions can offer new growth opportunities.

Key Takeaways from Analyst:

Global cardiopulmonary bypass equipment market growth is driven by rising prevalence of cardiovascular diseases worldwide. Growing geriatric population who are more prone to heart conditions can boost demand for cardiopulmonary bypass surgeries and equipment. Increasing investments by both public and private players to enhance healthcare infrastructure and encourage cardiac surgeries in developing nations can offer opportunities for market players.

High costs associated with bypass equipment and surgeries can hamper the market growth. The lack of reimbursement policies and limited accessibility to healthcare in low-income countries can also hamper the market growth. Stringent regulatory approvals for new product launches pose another challenge for manufacturers.

North America dominates the cardiopulmonary bypass equipment market due to robust healthcare infrastructure and rising healthcare expenditure in the region. Asia Pacific is likely to witness the fastest growth due to improving access to healthcare and rising medical tourism across developing countries like India and China.

Market Challenges: High cost of cardiopulmonary bypass equipment

High cost of cardiopulmonary bypass equipment can hamper the global cardiopulmonary bypass equipment market growth. Cardiopulmonary bypass, also known as heart-lung bypass, is an extracorporeal technique that temporarily takes over the function of the heart and lungs during surgery, thus, maintaining the circulation of blood and the oxygen content of the tissues. This allows the heart to be stopped, and works of repairing or correcting defects to be carried out. The equipment required for cardiopulmonary bypass includes the heart-lung machine, oxygenators, cannulae, blood cardioplegia systems, and cooling and warming devices. This specialized medical equipment is highly complex and incorporates advanced biomedical engineering technologies. Oxygenators use over 100,000 hollow fibers made from biocompatible polymers to effectively oxygenate blood outside the body. Due to stringent requirements for safety, reliability and sterile processing, materials and manufacturing of cardiopulmonary bypass equipment requires heavy investments. Furthermore, the devices need to undergo rigorous testing and clinical validations to obtain regulatory approvals.

Market Opportunities: Growing demand for minimally invasive procedures

Growing demand for minimally invasive surgical procedures  can offer market growth opportunities. Patients are increasingly opting for procedures that allow for smaller incisions, reduced pain and scarring, and shorter hospitalization times. This trend towards minimally invasive surgeries can drive the cardiopulmonary bypass equipment market growth. As hospitals and cardiac clinics cater to patient demand and preferences, these are investing more in equipment like miniaturized cardiopulseter pumps, low-volume cardiopulmonary bypass circuits, and portable heart-lung machines that support minimally invasive cardiac procedures. The availability of such advanced yet smaller bypass equipment enables complex cardiac surgeries to be performed through smaller access points rather than traditional open-heart operations. This leads to significantly faster recovery times for patients and reduced risk of surgical site infections. According to a 2021 report by the UN Department of Economic and Social Affairs, the global population aged 65 years and older is projected to double from 727 million to nearly 1.5 billion between 2020 and 2050. This growing geriatric population can increase age-related cardiac conditions that often require surgical treatment.

To learn more about this report, request a free sample copy

By Product Type, Single roller pump dominates the product type segment due to established use and cost effectiveness

By product type,  single roller pump segment is estimated to account for the highest market share of60.1% in 2024 due to its long-established use among cardiac surgeons and the cost-effectiveness it provides as compared to other pump designs. As one of the earliest pump designs developed for cardiopulmonary bypass procedures, the single roller pump has become the standard choice for most operations. Its simple roller-based pumping mechanism makes it a reliable workhorse that surgeons can use comfortably.  Single roller pump's design translates to lower production and maintenance costs relative to more complex multi-roller pumps. This cost advantage allows single roller pumps to be priced accessibly for healthcare facilities. Given the high volume of cardiopulmonary bypass surgeries performed worldwide each year, the lower total cost of ownership of single roller pumps is a compelling factor for hospitals and other end users. The pump's affordability makes it attainable for medical centers of all sizes.

By End User, High Prevalence and Mortality Rates

Among end user, hospitals segment is estimated to contribute the highest market  share of 40.12 % in 2024due to substantial case volume that is handled within hospital settings. As the default providers for life-threatening conditions like cardiovascular disease, hospitals perform by far the highest number of cardiopulmonary bypass surgeries each year. The scale of their cardiac programs all but ensures hospitals will see the most cardiopulmonary bypass equipment needs. Another benefit hospitals possess is established infrastructure for complex surgeries. Operating rooms, specialist staff, and postoperative care units allow hospitals to comfortably accommodate cardiopulmonary bypass procedures. Resources for equipment purchase and maintenance are also more readily available to hospitals as compared to other end users. Large metropolitan hospitals in particular have significant capital budgets that make the acquisition of premium cardiopulmonary bypass systems an obtainable investment. Follow-up service agreements can also be supported long-term. For equipment manufacturers, hospitals represent a low-risk consumer segment less vulnerable to budgetary constraints. As a result, manufacturers prioritize the specialized needs of hospital customers, further entrenching their leadership position. 

Regional Insights

To learn more about this report, request a free sample copy

North America has been leading the global cardiopulmonary bypass equipment market, accounting for over 36.2% of total transplants worldwide last year. The region's dominance is attributed to its advanced transplant centers, supportive reimbursement policies, and increasing awareness. The U.S. alone holds a market twice the size of any other country. Key medical device companies in North America invest heavily in research and development, ensuring continuous innovation in immunosuppressants, organ preservation solutions, and diagnostic tools for transplants. The region also imports organs due to a demand-supply imbalance.

However, Asia Pacific has emerged as the fastest-growing market due to rising chronic kidney disease incidences, growing incomes, and government initiatives to boost organ donation. China, in particular, has witnessed increase in transplants due to efforts to enhance local production, change donation rules, and increase affordability. This has attracted global medical technology firms to invest in partnerships and local manufacturing in China, reflecting the region's promising growth prospects.

Market Report Scope

Key Developments

• On January 9, 2024, Inspira Technology, a specialty medical device company,  launched a single-use disposable blood oxygenation kit. This kit, currently in development for its INSPIRA ART medical device series, is also being engineered to work seamlessly with other life support machines, including specific cardio-pulmonary bypass devices. By aiming to reduce costs and enhance efficiency in hospital budgets, this initiative represents a forward-looking approach to medical innovation.
• In March 2023, LivaNova, a medical device manufacturer, received FDA clearance for its Essenz Heart-Lung Machine (HLM), marking the launch of the Essenz Perfusion System in the U.S. This system, inclusive of the Essenz Patient Monitor, offers a patient-specific perfusion approach driven by data, enhancing clinical workflows and patient care during cardiopulmonary bypass procedures.

*Definition: Cardiopulmonary bypass equipment operates the heart and lungs and in turn circulates oxygenated blood throughout the body. It also maintains perfusion to other body tissues and organs while the surgeon works in a bloodless surgical field. The machine may consist of venous and arterial cannula (tubes), polyvinyl chloride (PVC) or silicone tubing, reservoir (to hold blood), bubbler or membrane oxygenator, cardiotomy (filtered reservoir), heat exchanger(s), arterial line filter, pump(s), flow meter, inline blood gas and electrolyte analyzer, and pressure-monitoring devices.

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Single Roller Pump
  • Double Roller Pump
•  End User Insights (Revenue, USD Mn, 2019 - 2031)
  • Hospitals
  • Ambulatory Surgical Centres
  • Others
• Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Medtronic
  • LivaNova (formerly Sorin Group)
  • Terumo Cardiovascular Systems Corporation
  • Maquet Holding BV & Co. KG
  • Braun Melsungen AG
  • Medica s.p.a.
  • Eurosets
  • Fresenius Medical Care AG & Co. KGaA
  • Lepu Medical Technology
  • Elite Life Care
  • OriGen Biomedical
  • Tianjin Medical
  • Soma Technology, Inc.
  • Braile Biomédica
  • CardioGenesis Corporation
  • Century Medical, Inc.
  • Nonin Medical, Inc.
  • Xijian Medical